Ovarian Stimulation With Recombinant Gonadotropins vs. Human Menopausal Gonadotropin in In Vitro Fertilization
Status:
Completed
Trial end date:
2014-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this retrospective study was to assess the outcome of In Vitro Fertilization
(IVF) according to the type of medication used for controlled ovarian stimulation (COS). The
study compared the pregnancy rate obtained by 398 patients who had received COS with
recombinant Follicle Stimulating Hormone (rFSH) plus recombinant Luteinising Hormone (rLH) in
2:1 ratio vs. the one observed in 450 patients who had been treated with human Menopausal
Gonadotropin (hMG), stratifying results according to the number of retrieved oocytes.